Trademark: 86449076
Word
THE MEDICINE BOX
Status
Dead
Status Code
606
Status Date
Monday, February 1, 2016
Serial Number
86449076
Mark Type
4000
Filing Date
Sunday, November 9, 2014
Published for Opposition
Tuesday, May 5, 2015
Abandoned Date
Monday, February 1, 2016

Trademark Owner History
The Medicine Box, Inc. - Owner At Publication

Classifications
5 Analgesic and muscle relaxant pharmaceutical preparations; Anti-epileptic pharmaceutical preparations; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment and/or prevention of Cancer, HIV/AIDS, ALS, Parkinson's Disease, MS, Damage to the nervous tissue of the spinal cord with neurological indications of intractable spasticity, Epilepsy, Inflammatory Bowel Disease, Neuropathies, and Huntington's Disease.; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Herb teas for medicinal purposes; Herbal teas for medicinal purposes; Herbs for medicinal purposes; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal oils; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the treatment and/or prevention of Cancer, HIV/AIDS, ALS, Parkinson's Disease, MS, Damage to the nervous tissue of the spinal cord with neurological indications of intractable spasticity, Epilepsy, Inflammatory Bowel Disease, Neuropathies, and Huntington's Disease.; Medicines for intestinal disorders; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of Cancer, HIV/AIDS, ALS, Parkinson's Disease, MS, Damage to the nervous tissue of the spinal cord with neurological indications of intractable spasticity, Epilepsy, Inflammatory Bowel Disease, Neuropathies, and Huntington's Disease.; Pharmaceutical preparations for the treatment and prevention of Cancer, HIV/AIDS, ALS, Parkinson's Disease, MS, Damage to the nervous tissue of the spinal cord with neurological indications of intractable spasticity, Epilepsy, Inflammatory Bowel Disease, Neuropathies, and Huntington's Disease.; Pharmaceutical preparations for the treatment of Cancer, HIV/AIDS, ALS, Parkinson's Disease, MS, Damage to the nervous tissue of the spinal cord with neurological indications of intractable spasticity, Epilepsy, Inflammatory Bowel Disease, Neuropathies, and Huntington's Disease.; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, elixirs for the treatment of Cancer, HIV/AIDS, ALS, Parkinson's Disease, MS, Damage to the nervous tissue of the spinal cord with neurological indications of intractable spasticity, Epilepsy, Inflammatory Bowel Disease, Neuropathies, and Huntington's Disease.; Plant extracts for medical, veterinary and pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Syrups for pharmaceutical purposes for the treatment of Cancer, HIV/AIDS, ALS, Parkinson's Disease, MS, Damage to the nervous tissue of the spinal cord with neurological indications of intractable spasticity, Epilepsy, Inflammatory Bowel Disease, Neuropathies, and Huntington's Disease
35 Administering pharmacy reimbursement programs and services; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Retail pharmacy services; Specialized retail pharmacy services for patients with particular medical conditions
44 Dispensing of pharmaceuticals; Medical and pharmaceutical consultation; Pharmaceutical advice; Pharmaceutical compounding services; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
MEDICINE

Trademark Events
Feb 1, 2016
Abandonment Notice Mailed - No Use Statement Filed
Feb 1, 2016
Abandonment - No Use Statement Filed
Jun 30, 2015
Noa E-Mailed - Sou Required From Applicant
May 5, 2015
Official Gazette Publication Confirmation E-Mailed
May 5, 2015
Published For Opposition
Apr 15, 2015
Notification Of Notice Of Publication E-Mailed
Mar 29, 2015
Law Office Publication Review Completed
Mar 29, 2015
Assigned To Lie
Mar 10, 2015
Approved For Pub - Principal Register
Mar 10, 2015
Examiner's Amendment Entered
Mar 10, 2015
Notification Of Examiners Amendment E-Mailed
Mar 10, 2015
Examiners Amendment E-Mailed
Mar 10, 2015
Examiners Amendment -Written
Mar 8, 2015
Notification Of Non-Final Action E-Mailed
Mar 8, 2015
Non-Final Action E-Mailed
Mar 8, 2015
Non-Final Action Written
Feb 28, 2015
Assigned To Examiner
Nov 17, 2014
New Application Office Supplied Data Entered In Tram
Nov 12, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24